MONTANOVA CAPITAL, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001569064

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q4 2023 · 88 positions · Total reported value $2.21B · Top-10 concentration 47.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 47.3% · 21 new · 17 cut · 14 exited

Active Share (vs S&P 500): 88.7% · vs QQQ: 90.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +26.5% · vs SPY +11.7% · Prev Value $3.92B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2023 13F filing, MONTANOVA CAPITAL, LLC disclosed 88 equity positions with a combined reported value of $2.21B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 47.1% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2023 were BHVN ($195.72M), ACLX ($135.20M), RPRX ($109.21M). By sector, the heaviest allocations are Health Care 46.9%, Technology 13.9%. Versus the prior quarter, allocation shifted toward Health Care (+6.2pp), Industrials (+2.7pp) and away from Other (-2.6pp), Technology (-3.9pp).

Versus the prior quarter, MONTANOVA CAPITAL, LLC opened 21 new positions, trimmed 17 and fully exited 14, a turnover rate of 47.3% of positions. The portfolio's overlap with the prior quarter was 73% of names.

The largest new positions opened in Q4 2023 were GS ($42.55M), TSM ($40.38M), FERG ($34.00M).

Of the 14 positions fully exited versus the prior quarter, the largest were HZNP ($90.97M), WYNN ($42.51M), NVDA ($38.52M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • GS GOLDMAN SACHS GROUP INC · $42.55M
  • TSM TAIWAN SEMICONDUCTOR MANUFAC · $40.38M
  • FERG FERGUSON ENTERPRISES INC · $34.00M
  • VZ VERIZON COMMUNICATIONS I · $27.03M
  • KWEB KRANESHARES TRUST · $24.30M
  • T AT&T INC · $20.47M
  • KRRO KORRO BIO INC · $3.54M
  • ALNY ALNYLAM PHARMACEUTICALS INC · $1.89M

Fully Exited (vs previous quarter)

  • HZNP HORIZON THERAPEUTICS PUB L · prev qtr: $90.97M
  • WYNN WYNN RESORTS LTD · prev qtr: $42.51M
  • NVDA NVIDIA CORPORATION · prev qtr: $38.52M · history
  • RH RH · prev qtr: $21.41M
  • LLY ELI LILLY & CO · prev qtr: $21.00M
  • COF CAPITAL ONE FINL CORP · prev qtr: $17.63M · history
  • WFC WELLS FARGO & CO · prev qtr: $17.51M
  • ALVO ALVOTECH · prev qtr: $8.47M

Insider Transactions (Form 4)

Latest MONTANOVA CAPITAL, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-08-20 Opt exercise Veradermics, Inc 151,000 — SEC filing
2026-08-20 Opt exercise Veradermics, Inc 149,000 — SEC filing
2026-08-19 Sell Veradermics, Inc 59,399 $107.25 SEC filing
2026-08-19 Sell Veradermics, Inc 690,601 $107.25 SEC filing

All insider transactions →

Fund Profile

Montanova Capital, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 96 positions worth $5.47B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-79962 (status: Approved), registered 2014-06-26
  • Regulatory AUM (Form ADV): $7.87B as of 2026-07-01
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 3 hedge funds
  • Website: montanova.com

Portfolio Structure

  • 96 positions · $5.47B reported value (Q2 2026)
  • Top 10 holdings = 49.1% of reported value
  • Largest position: SPY (STATE STR SPDR S&P 500 ETF T) at 13.0%
  • Average position size: $56.96M

Sector Tilt

  • Health Care 50.9%
  • Information Technology 14.5%
  • Consumer Discretionary 8.3%
  • (classified holdings cover 83% of value)

Quarterly Activity

  • Q2 2026: 21 new, 26 added, 17 reduced, 14 exited
  • 32 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 46.9%
Technology 13.9%
Financials 4.2%
Other 19.8%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 4.57M $195.72M 8.85%
8.85%
Add
2 2.44M $135.20M 6.11%
6.11%
Reduce
3 3.89M $109.21M 4.94%
4.94%
Reduce
4 2.13M $101.68M 4.60%
4.60%
Add
5 6.95M $99.89M 4.52%
4.52%
Reduce
6 4.06M $93.75M 4.24%
4.24%
Add
7 1.17M $83.51M 3.77%
3.77%
Reduce
8 2.68M $83.19M 3.76%
3.76%
Reduce
9 220.18K $77.94M 3.52%
3.52%
Reduce
10 161.92K $60.89M 2.75%
2.75%
Reduce
11 5.35M $58.11M 2.63%
2.63%
Add
12 368.09K $55.93M 2.53%
2.53%
Reduce
13 4.89M $54.60M 2.47%
2.47%
Add
14 540.82K $50.40M 2.28%
2.28%
Add
15 333.47K $49.16M 2.22%
2.22%
Reduce
16 356.18K $45.46M 2.06%
2.06%
Add
17 110.31K $42.55M 1.92%
1.92%
New
18 388.23K $40.38M 1.82%
1.82%
New
19 694.10K $40.13M 1.81%
1.81%
Add
20 5.84M $37.88M 1.71%
1.71%
Reduce
21 5.52M $37.25M 1.68%
1.68%
Reduce
22 738.16K $36.33M 1.64%
1.64%
Add
23 176.09K $34.00M 1.54%
1.54%
New
24 322.05K $33.95M 1.53%
1.53%
Add
25 2.68M $32.88M 1.49%
1.49%
Add
26 63.46K $29.38M 1.33%
1.33%
Add
27 96.30K $28.84M 1.30%
1.30%
Add
28 8.47M $27.37M 1.24%
1.24%
Add
29 716.85K $27.03M 1.22%
1.22%
New
30 53.73K $25.34M 1.15%
1.15%
Add
31 5.78M $24.79M 1.12%
1.12%
Reduce
32 900.00K $24.30M 1.10%
1.10%
New
33 3.71M $21.82M 0.99%
0.99%
Add
34 1.22M $20.47M 0.93%
0.93%
New
35 53.70K $20.43M 0.92%
0.92%
Add
36 8.71K $19.92M 0.90%
0.90%
Reduce
37 109.26K $19.90M 0.90%
0.90%
Reduce
38 957.30K $18.28M 0.83%
0.83%
Add
39 7.37M $17.03M 0.77%
0.77%
Hold
40 914.48K $16.53M 0.75%
0.75%
Reduce
41 112.38K $14.27M 0.65%
0.65%
Reduce
42 90.10K $14.12M 0.64%
0.64%
Hold
43 2.85M $13.31M 0.60%
0.60%
Hold
44 5.73M $9.35M 0.42%
0.42%
Hold
45 614.30K $9.15M 0.41%
0.41%
Add
46 399.45K $8.90M 0.40%
0.40%
Reduce
47 171.00K $8.50M 0.38%
0.38%
Add
48 354.87K $7.60M 0.34%
0.34%
Reduce
49 3.87M $6.88M 0.31%
0.31%
Hold
50 7.17M $6.79M 0.31%
0.31%
Hold

FAQ

What did MONTANOVA CAPITAL, LLC buy in 2023-Q4?

In its 2023-Q4 13F filing, MONTANOVA CAPITAL, LLC reported 88 equity positions worth $2.21B in aggregate; its largest disclosed positions were BHVN ($195.72M), ACLX ($135.20M), RPRX ($109.21M).

How large is MONTANOVA CAPITAL, LLC's portfolio?

MONTANOVA CAPITAL, LLC reported $2.21B of long equity holdings across 88 positions as of 2023-Q4. Top-10 holdings account for 47.1% of reported value.

What is MONTANOVA CAPITAL, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/montanova-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →